A multi-center, double-blind, randomized, parallel design study to compare the effectiveness of suvorexant versus placebo on sleep pressure and circadian rhythm in insomniacs with hypertension: The Super 1 study

Trial Profile

A multi-center, double-blind, randomized, parallel design study to compare the effectiveness of suvorexant versus placebo on sleep pressure and circadian rhythm in insomniacs with hypertension: The Super 1 study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Jan 2017

At a glance

  • Drugs Suvorexant (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Acronyms Super 1
  • Most Recent Events

    • 19 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 16 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top